证券代码：300174 证券简称：元力股份 公告编号：2026-010 福建元力活性炭股份有限公司 关于首次回购公司股票的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 福建元力活性炭股份有限公司（以下简称"公司"）于 2026 年 2 月 24 日召开的第六届董事会第十二次会议审议通过了《关于回购公司 股份方案的议案》：同意公司以不低于人民币 5,000 万元且不超过人民 币 6,000 万元的自有资金通过集中竞价交易的方式回购公司发行的人 民币普通股（A 股）股票，回购价格不超过 20 元/股，回购期限为自公 司董事会审议通过本次回购股份方案之日起 12 个月内。本次回购股份 方案具体内容详见公司于 2026 年 2 月 25 日在中国证监会指定创业板 信息披露网站上披露的《关于回购公司股份方案的公告》及 2026 年 2 月 26 日披露的《回购报告书》。 （2）中国证监会和深圳证券交易所规定的其他情形。 2、公司以集中竞价交易方式回购公司股份符合下列要求： （1）委托价格不得为公司股票当日交易涨幅限制的价格； （2）不得在深圳证券交易所开盘集合竞 ...

证券代码：300174 证券简称：元力股份 公告编号：2026-009 福建元力活性炭股份有限公司 关于回购公司股份进展的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 福建元力活性炭股份有限公司（以下简称"公司"）于 2026 年 2 月 24 日召开的第六届董事会第十二次会议审议通过了《关于回购公司 股份方案的议案》：同意公司以不低于人民币 5,000 万元且不超过人 民币 6,000 万元的自有资金通过集中竞价交易的方式回购公司发行的 人民币普通股（A 股）股票，回购价格不超过 20 元/股，回购期限为自 公司董事会审议通过本次回购股份方案之日起 12 个月内。本次回购股 份方案具体内容详见公司于 2026 年 2 月 25 日在中国证监会指定创业 板信息披露网站上披露的《关于回购公司股份方案的公告》及 2026 年 2 月 26 日披露的《回购报告书》。 根据《上市公司股份回购规则》《深圳证券交易所上市公司自律 监管指引第 9 号——回购股份》等有关规定，现将公司回购股份的进 展情况公告如下： 二〇二六年三月四日 一、回购公司股份的进展 截至 2 ...

福建元力活性炭股份有限公司 关于延期回复《关于福建元力活性炭股份有限公司发行股份及 支付现金购买资产并募集配套资金申请的审核问询函》的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 福建元力活性炭股份有限公司（以下简称"公司"）拟通过发行 股份及支付现金的方式收购福建同晟新材料科技股份公司 100%股权并 募集配套资金（以下简称"本次交易"）。 公司于 2026 年 1 月 5 日收到深圳证券交易所出具的《关于福建元 力活性炭股份有限公司发行股份及支付现金购买资产并募集配套资金 申请的审核问询函》（审核函〔2026〕030001 号，以下简称"审核问 询函"），要求公司在 30 日内对审核问询函中所列问题逐项落实并提 交书面回复。收到《审核问询函》后，公司及相关中介机构根据《审 核问询函》的要求，就相关事项进行了逐项说明、论证和回复，并于 2026 年 1 月 31 日披露了相关回复文件。 根据深圳证券交易所的进一步审核意见，公司需对《审核问询函》 回复文件进行修改、补充，因进一步修改、补充所需工作时间较长， 根据《深圳证券交易所上市公司重大资产重组审核 ...

证券代码：300174 证券简称：元力股份 公告编号：2026-006 福建元力活性炭股份有限公司 回购报告书 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 1、福建元力活性炭股份有限公司（以下简称"公司"）拟使用自 有资金以集中竞价交易的方式回购公司股份（以下简称"本次回购"）， 用于实施股权激励计划或员工持股计划，回购股份的种类为公司发行 的人民币普通股（A 股）。本次回购股份资金总额不低于人民币 5,000 万元且不超过人民币 6,000 万元，回购股份价格不超过人民币 20 元/ 股；回购期限自董事会审议通过回购股份议案之日起不超过 12 个月； 如国家对相关政策作调整，则本回购方案按调整后的政策实行。 2、公司董事、高级管理人员，控股股东、实际控制人及其一致行 动人回购期间不存在明确的增减持计划，公司合计持股 5%以上的股东 及其一致行动人未来六个月亦不存在明确的减持计划。 3、相关风险提示： 4、公司已在中国证券登记结算有限责任公司深圳分公司开立了 回购专用证券账户。 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华 ...

证券代码：300174 证券简称：元力股份 公告编号：2026-007 福建元力活性炭股份有限公司 关于回购股份事项前十名股东持股情况的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 福建元力活性炭股份有限公司（以下简称"公司"）于 2026 年 2 月 24 日召开第六届董事会第十二次会议，审议通过了《关于回购公司 股份方案的议案》，具体内容详见公司于 2026 年 2 月 25 日在中国证 监会创业板指定信息披露网站披露的《关于回购公司股份方案的公告》。 根据《深圳证券交易所上市公司自律监管指引第 9 号——回购股 份》等相关规定，现将公司董事会公告回购股份决议前一交易日（即 2026 年 2 月 24 日）登记在册的前十名股东和前十名无限售条件股东的 名称及持股数量、比例情况公告如下： | 9 | 袁永林 | 3,797,900 | 1.04% | | --- | --- | --- | --- | | 10 | 上海睿郡资产管理有限公司－睿郡有孚 号私募证券投资基金 | 3 3,540,919 | 0.97% | 注：以上股东的持股数量为合并普通 ...

Group 1: Financial Performance - Hengyu Environmental reported a revenue of 294 million yuan for 2025, an increase of 89.87%, and a net profit of 35.93 million yuan, up 106.25% [1] - Zhongke Shuguang achieved a revenue of 14.97 billion yuan in 2025, growing by 13.86%, with a net profit of 2.113 billion yuan, reflecting a 10.54% increase [2] - Oat Technology's revenue reached 619 million yuan, marking a 24.33% growth, and a net profit of 137 million yuan, up 42.63% [4] - Yongxi Electronics reported a revenue of 4.4 billion yuan, a 21.92% increase, with a net profit of 82.24 million yuan, up 23.99% [5] Group 2: Shareholder Actions - Yashida Optoelectronics announced that a shareholder plans to reduce holdings by up to 1.6 million shares, representing no more than 0.976% of the total share capital [3] - Yuanli Co. intends to repurchase shares worth 50 to 60 million yuan for employee stock ownership plans, with a maximum repurchase price of 20 yuan per share [6] - Conch Cement's controlling shareholder plans to increase holdings by 700 million to 1.4 billion yuan [7] - Huaneng Hydropower's controlling shareholder plans to increase holdings by 100 to 150 million yuan [8] Group 3: Corporate Announcements - Baotai's drug application for Darpobatin injection has been accepted by the National Medical Products Administration [14] - Changchun High-tech's subsidiary received approval for clinical trials of GenSci141 ointment [15] - Tongwei Co. is planning to acquire 100% of Lihua Qingneng, with stock trading suspended for up to 10 trading days [16] - Guoyao Modern's application for the raw material drug Minaprine has been approved [20] Group 4: Market Activities - Kaipu Cloud announced the termination of the acquisition of Nanning Taike [21] - Boji Pharmaceutical plans to reduce its holdings by up to 0.69% of the total share capital [23] - ST Renfu intends to issue shares to its controlling shareholder to raise 3 to 3.5 billion yuan for innovative drug development projects [24] - Huayi Technology submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [25]

Group 1: Market Trends and Risks - Roman Shares and Meibang Shares have experienced significant short-term stock price increases, indicating potential market sentiment overheating and irrational speculation risks [1][1] Group 2: Project Investments - Dazhu Laser plans to invest $150 million to establish an overseas operation center in Southeast Asia [1] - Bohai Leasing's subsidiary Avolon intends to sell aircraft leasing assets worth approximately 11.061 billion yuan [1] Group 3: Contract Awards - Fengfan Shares has won a bid for a project with Southern Power Grid valued at approximately 184 million yuan [1] - ST Songfa's subsidiary has signed contracts for the construction of two Capesize bulk carriers [1] Group 4: Financial Performance - Zhongke Shuguang expects a net profit of 2.113 billion yuan for 2025, representing a year-on-year increase of 10.54% [2] - Zhongjiao Technology anticipates a net profit of 156 million yuan for 2025, up 86.13% year-on-year [2] - Sry New Materials forecasts a net profit of 154 million yuan for 2025, reflecting a 35.04% year-on-year growth [2] - Wen's Shares projects a net profit of 5.235 billion yuan for 2025, down 43.59% year-on-year [2] Group 5: Equity Acquisitions - Changxin Bochuang plans to acquire 93.8108% equity in Shanghai Honghui Optical Communication Technology [3] - Shenlian Bio intends to acquire controlling rights of Shizhi Source for 237 million yuan and to develop new business [3] - Tongwei Co. plans to purchase 100% equity of Lihua Qingneng, with stock suspension [3] Group 6: Share Buybacks - Kaipu Cloud plans to repurchase shares worth 50 million to 100 million yuan [3] - Zhongshun Jierou intends to buy back shares worth 60 million to 120 million yuan [3] - Yuanli Co. plans to repurchase shares worth 50 million to 60 million yuan [3] Group 7: Shareholding Changes - Conch Cement plans to increase its A-share holdings by 700 million to 1.4 billion yuan [3] - Fushi Holdings' Song Chunqing intends to reduce holdings by no more than 2% [3] - Zhixin Precision's director Zhang Guojun plans to reduce holdings by no more than 1.8562% [3] - Yashida Optoelectronics' director Lin Xuefeng plans to reduce holdings by no more than 0.976% [3] Group 8: Other Developments - ST Renfu plans to raise 3 billion to 3.5 billion yuan through a private placement to its controlling shareholder, Zhaoshang Biotechnology [4] - ST Xiangxue has received a decision to extend the pre-restructuring period [4] - Kaipu Cloud has terminated a major asset restructuring [4]

Group 1 - The core viewpoint of the news is that Yuanli Co., Ltd. has shown fluctuations in its stock performance and financing activities, indicating a low level of financing and short-selling activity [1][2]. - On February 24, Yuanli's stock increased by 2.07%, with a trading volume of 134 million yuan. The financing buy-in amount was 23.98 million yuan, while the financing repayment was 37.77 million yuan, resulting in a net financing outflow of 13.79 million yuan [1]. - As of February 24, the total balance of margin trading for Yuanli was 517 million yuan, which accounts for 8.47% of its market capitalization, indicating a low financing balance compared to the past year [1]. Group 2 - As of September 30, the number of shareholders for Yuanli was 16,500, a decrease of 0.80% from the previous period, while the average circulating shares per person increased by 0.80% to 21,951 shares [2]. - For the period from January to September 2025, Yuanli reported a revenue of 1.408 billion yuan, representing a year-on-year growth of 0.82%. However, the net profit attributable to shareholders decreased by 18.61% to 173 million yuan [2]. - Yuanli has distributed a total of 368 million yuan in dividends since its A-share listing, with 174 million yuan distributed over the past three years [2].

Performance Summary - Supor reported a net profit of 2.097 billion yuan for 2025, a decrease of 6.58% year-on-year [2] - Sanofi reported a net profit of 2.939 billion yuan for 2025, an increase of 317.09% year-on-year [17] - Wens Foodstuff Group reported a net profit of 5.235 billion yuan for 2025, a decrease of 43.59% year-on-year [18] - Sree New Materials reported a net profit of 154 million yuan for 2025, an increase of 35.04% year-on-year [22] - JiaoKong Technology reported a net profit of 156 million yuan for 2025, an increase of 86.13% year-on-year [22] - Aidi Pharmaceutical reported a net loss of 19.7337 million yuan for 2025, a reduction in loss [22] - MicroGuide Nano reported a net profit of 213 million yuan for 2025, a decrease of 6.12% year-on-year [22] - Zhongwei Semiconductor reported a net profit of 285 million yuan for 2025, an increase of 108.05% year-on-year [22] - Hengyu Environmental reported a net profit of 35.9325 million yuan for 2025, an increase of 106.25% year-on-year [22] - Zhongke Shuguang reported a net profit attributable to shareholders of 2.113 billion yuan for 2025, an increase of 10.54% year-on-year [22] - Oat Technology reported a net profit of 137 million yuan for 2025, an increase of 42.63% year-on-year [22] - Yongxi Electronics reported a net profit attributable to shareholders of 82.2403 million yuan for 2025, an increase of 23.99% year-on-year [22] Shareholding Changes - Asia Optical's shareholders plan to reduce their holdings by no more than 1.6 million shares [22] - Anhui Conch Cement's controlling shareholder plans to increase its holdings by 700 million to 1.4 billion yuan [22] - Huaneng Hydropower's controlling shareholder plans to increase its holdings by 100 million to 150 million yuan [22] - Fushi Holdings' shareholders plan to reduce their holdings by no more than 2% [22] - Zhixin Precision's board members plan to reduce their holdings by no more than 1.8562% [22] - Hongbaoli's deputy general manager plans to reduce their holdings by no more than 310,000 shares [22] - Yuanli Co. plans to repurchase shares worth 50 million to 60 million yuan [22] - Zhongshun Jierou plans to repurchase shares worth 60 million to 120 million yuan [22] Contract Awards - Fengfan Co. won a procurement project from Southern Power Grid worth approximately 184 million yuan [22] - Shaoneng Co.'s wholly-owned subsidiary signed a cooperation agreement for land and resources for an independent energy storage power station project with Yuancan Company [22] Major Investments - Zhejiang Medicine plans to invest 250 million yuan in a silver economy fund in collaboration with a private equity fund [4] Project Approvals - Gansu Energy's Minqin Shuangchike 2 million kilowatt wind power project has been approved [5] - China Tianying received investment approval for the expansion of its Hanoi project [5] Mergers and Acquisitions - Dazhu Laser plans to invest 150 million USD to establish an overseas operation center [6] - Dongyang Sunshine is planning to acquire control of Dongshu No. 1, with stock suspension [6] - Shenlian Bio plans to acquire control of Shizhi Source for 237 million yuan to fully develop its innovative drug business [23] - Tongwei is planning to purchase 100% of Lihua Qingneng, with stock suspension starting tomorrow [23] - Changxin Bochuang plans to acquire 93.8108% of Shanghai Honghui Optical Communication Technology Co., Ltd. for 375 million yuan [23] - Kaipu Cloud has terminated the acquisition of 100% of Nanning Taike [23] Other Developments - Kexin Mechanical and Electrical obtained a production license for ultra-high pressure containers (A6) [10] - Baiyin Nonferrous Metals received a government subsidy of 9 million yuan [24] - Rundou Co. received a drug registration certificate for ibuprofen tablets [25] - Hengrui Medicine's application for the marketing authorization of the innovative drug SHR-1918 injection has been accepted and included in the priority review process [26] - Duorui Medicine's tender offer period has expired, and the company's stock is suspended [27] - Inner Mongolia Huadian plans to apply for a change of its stock name to "Huaneng Mengdian" [28]

Group 1: Share Buybacks - Companies such as Zhongshun Jierou and Yuanli Co. have announced new share buyback plans, with Zhongshun Jierou planning to repurchase shares at a price not exceeding 12.4 yuan per share, with a total fund of no less than 60 million yuan and no more than 120 million yuan [1] - Kaipu Cloud plans to repurchase shares with a total fund of no less than 50 million yuan and no more than 100 million yuan, at a price not exceeding 315 yuan per share [1] - Aidi Precision has repurchased 209,000 shares for a total payment of approximately 5.09 million yuan, as part of a buyback plan with a total fund range of 100 million to 200 million yuan [3] Group 2: Shareholder Increases - Conch Cement's controlling shareholder, Conch Group, plans to increase its stake in the company with a minimum investment of 700 million yuan and a maximum of 1.4 billion yuan within six months [2] - Huaneng Hydropower's controlling shareholder's investment fund has increased its stake by 3.276 million shares for a total of 30.02 million yuan, with plans to continue increasing its stake by an estimated total of 100 million to 150 million yuan [2] - Fuguang Co. reported that its controlling shareholder has cumulatively increased its stake by 233,300 shares, costing approximately 6.76 million yuan, with plans for further increases [2] Group 3: Buyback Progress - Xingsui Technology has cumulatively repurchased 2.98 million shares, with total payments exceeding 68.41 million yuan, surpassing the lower limit of its buyback plan [3] - Jiutian Pharmaceutical has completed its buyback plan, having repurchased 6.1808 million shares, accounting for 1.24% of the total share capital, with a total transaction amount reaching 100 million yuan [3]